Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa plaque test of topical valrubicin cream for psoriasis vulgaris
2009-017692-18Phase 2Completed
- Sponsor
- ValDerm
- Start
- Dec 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of valrubicin in plaque psoriasis (4 arms), sponsored by ValDerm. Primary endpoint: Reduction of infiltrate thickness. Started Dec 2009; status: completed.
02
Drugs
valrubicin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2009-017692-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017692-18.